Baylor College of Medicine: Examining Outcomes in Children With Down Syndrome and Acute Lymphoblastic Leukemia
October 31, 2023
October 31, 2023
HOUSTON, Texas, Oct. 31 (TNSres) -- The Baylor College of Medicine issued the following news:
Children with Down syndrome have an increased risk of developing acute lymphoblastic leukemia (ALL) and experience higher rates of relapse and treatment toxicity. In recent decades, new therapies have improved outcomes for the general population, but outcomes for children with Down syndrome have lagged and have not been reported for contemporary treatment regimens.
A new report . . .
Children with Down syndrome have an increased risk of developing acute lymphoblastic leukemia (ALL) and experience higher rates of relapse and treatment toxicity. In recent decades, new therapies have improved outcomes for the general population, but outcomes for children with Down syndrome have lagged and have not been reported for contemporary treatment regimens.
A new report . . .